Home > Publications > Medical Specialty > Internal Medicine > Endocrinology > Diabetes > American Diabetes Association 2025 Conference Review
American Diabetes Association 2025 Conference Review

American Diabetes Association 2025 Conference Review

In this edition:

FORWARD: a novel allogeneic stem cell-derived islet cell therapy for type 1 diabetes
BELIEVE: bimagrumab + semaglutide in overweight/obesity
STRIDE sub-analysis: semaglutide benefits across diabetes characteristics
ACHIEVE-1: orforglipron in drug-naïve type 2 diabetes
REDEFINE 2: cagrilintide + semaglutide in type 2 diabetes with overweight/obesity
A GPT-based AI model for diabetes education
ADJUST-T1D: add-on semaglutide in type 1 diabetes
Dementia risks with SGLT2is/GLP-1 RAs in type 2 diabetes
Functional MRI findings in painful diabetic neuropathy
QWINT-4: efsitora vs. insulin glargine U100 in type 2 diabetes treated with basal & prandial insulin

You need to be logged in to access this content.

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.

It looks like you are closest to our New Zealand site.

Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.